MedTrace Logo

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

NCT07059689 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-07-11

No results posted yet for this study

Summary

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Conditions

  • Heart Defects, Congenital
  • Intensive Care Units, Pediatric
  • Respiration, Artificial
  • Extubation

Interventions

DEVICE

High Flow Nasal Cannula (HFNC)

Participants in this arm will receive High Flow Nasal Cannula therapy using the Airvo™3 Nasal High Flow System immediately after planned extubation following cardiac surgery

DEVICE

Non-Invasive Ventilation (NIV)

Participants in this arm will receive Non-Invasive Ventilation (NIV) immediately after planned extubation following cardiac surgery. NIV will be delivered using standard ICU ventilator settings, with parameters tailored to each patient's clinical condition

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Head of Pediatric Emergency and Intensive Care Divison · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07059689 on ClinicalTrials.gov